
|Videos|September 12, 2021
Dr. Elliot on ROBUST III trial of Optilume drug-coated balloon for anterior urethral strictures
Author(s)Urology Times staff
Advertisement
In this video, Sean P. Elliott, MD, MS, FACS, discusses the abstract, “Interim results for the ROBUST III trial evaluating the Optilume drug-coated balloon for anterior urethral strictures,” which was presented during the 2021 American Urological Association annual meeting. Elliott is a professor, vice chair of urology, and director of reconstructive urology at the University of Minnesota, Minneapolis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical tips for AE management with the gemcitabine intravesical system
2
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
3
Study to assess adaptive-dosed 177Lu-DOTA-HYNIC-panPSMA in mHSPC
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5












